Dambkowski Carl
Chief Medical Officer
Dambkowski Carl has filed 17 SEC Form 4 filings (49 transaction rows) across 2 companies, including APGE, ORKA, with disclosures dating back to 2025. 17 of those filings fall inside the rolling window. Most recent filing: Aug 8, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$18.9M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| APGE | Chief Medical Officer | Sale | 5,500 | $738K | Aug 8 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $730K | Jul 2 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 26,400 | $3.5M | Jun 25 | SEC ↗ | |
| ORKA | Director | Sale | 22,417 | $1.6M | Jun 12 | SEC ↗ | |
| ORKA | Director | Sale | 12,583 | $882K | Jun 12 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $433K | Jun 6 | SEC ↗ | |
| ORKA | Director | Sale | 105,000 | $6.2M | May 22 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $463K | May 8 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $467K | Apr 3 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $391K | Mar 6 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $362K | Feb 4 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 18,700 | $1.5M | Jan 9 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 10,900 | $818K | Dec 5 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 10,785 | $594K | Nov 7 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,110 | $203K | Oct 3 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 2,725 | $103K | Sep 5 | SEC ↗ |